Capital Flow Monitor · Sponsors · CIK 1759388
TMRW Life Sciences, Inc.
250 HUDSON STREET, NEW YORK, NY, 10013 · 917-525-3453
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$38.4M
Sold
$38.4M
% sold
100.0%
Investors
59
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-24 | D ·current | 506(b) | $38.4M | $38.4M | 100.0% | 59 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Vinay Shah — Director, New York, NY
1 other raise
- ADIAL PHARMACEUTICALS, INC. $4.3M of $4.3M · 100.0%
- Louis Villalba — Executive Officer / Director, New York, NY
-
Andrew Schwab — Director, New York, NY
2 other raises
- S2N Health Inc. $3.0M of $3.0M · 100.0%
- Ride Health, Inc. $15.5M of $16.4M · 94.5%
- William Schoolcraft — Director, New York, NY
- Jeffrey Port — Director, New York, NY
- Greg Eisner — Director, New York, NY
- Emily Drabant Conley — Director, New York, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.